57
Participants
Start Date
August 1, 2023
Primary Completion Date
June 29, 2024
Study Completion Date
October 1, 2024
Albumin
In the first phase of the study, a 3 + 3 dose-escalation study with 7 doses (0.25g/kg, 0.35g/kg, 0.40g/kg, 0.45g/kg, 0.5g/kg, 0.55g/kg, 0.60g/kg). Intra-arterial albumin infusion will be applied after successful recanalization of the culprit artery in the anterior circulation. In the second phase of the study, at the maximum safe dose determined in the first phase, an additional 15 to 20 patients will be enrolled for intra-arterial albumin infusion.
Tianjin Huanhu Hospital, Tianjin
Tianjin Huanhu Hospital
OTHER